vs

Side-by-side financial comparison of GERON CORP (GERN) and Plymouth Industrial REIT, Inc. (PLYM). Click either name above to swap in a different company.

Plymouth Industrial REIT, Inc. is the larger business by last-quarter revenue ($51.2M vs $47.2M, roughly 1.1× GERON CORP). GERON CORP runs the higher net margin — -39.0% vs -106.3%, a 67.2% gap on every dollar of revenue. On growth, GERON CORP posted the faster year-over-year revenue change (67.1% vs -1.4%). Over the past eight quarters, GERON CORP's revenue compounded faster (1597.0% CAGR vs 0.4%).

Geron Corporation is a biotechnology company located in Foster City, California which specializes in developing and commercializing therapeutic products for cancer that inhibit telomerase.

Plymouth Industrial REIT, Inc. is a real estate investment trust focused on owning, operating, and acquiring high-quality industrial properties including distribution centers, warehouses, and light industrial facilities across key U.S. logistics hubs. It serves tenants in e-commerce, retail, manufacturing, and third-party logistics sectors, supporting diverse business supply chain needs.

GERN vs PLYM — Head-to-Head

Bigger by revenue
PLYM
PLYM
1.1× larger
PLYM
$51.2M
$47.2M
GERN
Growing faster (revenue YoY)
GERN
GERN
+68.4% gap
GERN
67.1%
-1.4%
PLYM
Higher net margin
GERN
GERN
67.2% more per $
GERN
-39.0%
-106.3%
PLYM
Faster 2-yr revenue CAGR
GERN
GERN
Annualised
GERN
1597.0%
0.4%
PLYM

Income Statement — Q3 FY2025 vs Q3 FY2025

Metric
GERN
GERN
PLYM
PLYM
Revenue
$47.2M
$51.2M
Net Profit
$-18.4M
$-54.4M
Gross Margin
Operating Margin
-29.4%
-102.5%
Net Margin
-39.0%
-106.3%
Revenue YoY
67.1%
-1.4%
Net Profit YoY
30.3%
-248.5%
EPS (diluted)
$-0.03
$-1.23

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GERN
GERN
PLYM
PLYM
Q3 25
$47.2M
$51.2M
Q2 25
$49.0M
$47.2M
Q1 25
$39.6M
$45.6M
Q4 24
$47.6M
Q3 24
$28.3M
$51.9M
Q2 24
$882.0K
$48.7M
Q1 24
$304.0K
$50.2M
Q4 23
$23.0K
$50.8M
Net Profit
GERN
GERN
PLYM
PLYM
Q3 25
$-18.4M
$-54.4M
Q2 25
$-16.4M
$-6.1M
Q1 25
$-19.8M
$5.8M
Q4 24
$147.4M
Q3 24
$-26.4M
$-15.6M
Q2 24
$-67.4M
$1.3M
Q1 24
$-55.4M
$6.2M
Q4 23
$9.3M
Operating Margin
GERN
GERN
PLYM
PLYM
Q3 25
-29.4%
-102.5%
Q2 25
-25.4%
-10.3%
Q1 25
-42.2%
Q4 24
Q3 24
-99.8%
-29.6%
Q2 24
-7860.9%
2.7%
Q1 24
-18465.1%
Q4 23
Net Margin
GERN
GERN
PLYM
PLYM
Q3 25
-39.0%
-106.3%
Q2 25
-33.4%
-12.9%
Q1 25
-50.1%
12.8%
Q4 24
309.9%
Q3 24
-93.5%
-30.1%
Q2 24
-7639.8%
2.7%
Q1 24
-18220.4%
12.4%
Q4 23
18.3%
EPS (diluted)
GERN
GERN
PLYM
PLYM
Q3 25
$-0.03
$-1.23
Q2 25
$-0.02
$-0.14
Q1 25
$-0.03
$0.13
Q4 24
$3.24
Q3 24
$-0.04
$-0.35
Q2 24
$-0.10
$0.03
Q1 24
$-0.09
$0.14
Q4 23
$0.21

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GERN
GERN
PLYM
PLYM
Cash + ST InvestmentsLiquidity on hand
$78.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$248.7M
$470.1M
Total Assets
$567.4M
$1.6B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GERN
GERN
PLYM
PLYM
Q3 25
$78.1M
Q2 25
$77.7M
Q1 25
$83.7M
Q4 24
Q3 24
$60.3M
Q2 24
$116.9M
Q1 24
$189.8M
Q4 23
$70.0M
Total Debt
GERN
GERN
PLYM
PLYM
Q3 25
Q2 25
Q1 25
Q4 24
$646.4M
Q3 24
Q2 24
Q1 24
Q4 23
$873.4M
Stockholders' Equity
GERN
GERN
PLYM
PLYM
Q3 25
$248.7M
$470.1M
Q2 25
$259.5M
$539.6M
Q1 25
$268.2M
$571.0M
Q4 24
$579.5M
Q3 24
$292.3M
$436.5M
Q2 24
$306.7M
$475.2M
Q1 24
$344.9M
$484.6M
Q4 23
$247.9M
$483.0M
Total Assets
GERN
GERN
PLYM
PLYM
Q3 25
$567.4M
$1.6B
Q2 25
$555.2M
$1.6B
Q1 25
$562.5M
$1.4B
Q4 24
$1.4B
Q3 24
$444.9M
$1.5B
Q2 24
$449.4M
$1.4B
Q1 24
$482.1M
$1.4B
Q4 23
$394.1M
$1.4B
Debt / Equity
GERN
GERN
PLYM
PLYM
Q3 25
Q2 25
Q1 25
Q4 24
1.12×
Q3 24
Q2 24
Q1 24
Q4 23
1.81×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GERN
GERN
PLYM
PLYM
Operating Cash FlowLast quarter
$-13.6M
$20.0M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GERN
GERN
PLYM
PLYM
Q3 25
$-13.6M
$20.0M
Q2 25
$-27.4M
$23.4M
Q1 25
$-48.0M
$15.6M
Q4 24
$96.1M
Q3 24
$-58.9M
$17.6M
Q2 24
$-53.5M
$19.9M
Q1 24
$-62.3M
$16.6M
Q4 23
$-167.7M
$18.6M
Free Cash Flow
GERN
GERN
PLYM
PLYM
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
$-53.7M
Q1 24
$-62.9M
Q4 23
$-168.6M
FCF Margin
GERN
GERN
PLYM
PLYM
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
-6086.6%
Q1 24
-20680.3%
Q4 23
-732926.1%
Capex Intensity
GERN
GERN
PLYM
PLYM
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
0.0%
Q2 24
23.4%
Q1 24
202.3%
Q4 23
3608.7%
Cash Conversion
GERN
GERN
PLYM
PLYM
Q3 25
Q2 25
Q1 25
2.67×
Q4 24
0.65×
Q3 24
Q2 24
15.12×
Q1 24
2.67×
Q4 23
2.01×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons